Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response on the IFW for the '148 app 90/008,227 now. eom

If you don't mind. I'll put my 2 cents in while we await if Milestone will respond.

One has to presume that this expiration of a patent while being reexamined doesn't happen all that often. And in the handful of cases that it does occur, how often does the patent owner conveniently have court claim constructions to use to defend claims? Might HTC and Acer trial lawyers be scrambling to understand the rammifications of what Henneman just did?

Henneman may have just pulled a rabbit out of the hat. I'm hoping it surpised everyone, and puts dynamics of settlement negoitiations in a different light. It should IMHO.

Opty

Share
New Message
Please login to post a reply